GlaxoSmithKline is placing a $95 million wager on the significance of the "living genome," a term for the noncoding DNA that appear to regulate how genes function in different cells, states of disease and environments. The initiative will lean heavily on computer scientists, who will make up some of the 40 to 80 researchers that will be hired using the Glaxo funds.
The struggling GlaxoSmithKline is committing more than $95 million in cash and added resources over the next 5 years to launch a new nonprofit institute in Seattle that will explore the "living genome" for new insights into the ways that cells function in search of a new generation of drugs to put into the clinic.
A husband-and-wife team of corporate investigators imprisoned in China for illegally obtaining private records of Chinese citizens and selling the information to clients including GlaxoSmithKline were deported on Wednesday, Reuters reported.
Another week, another rumor about the target on GlaxoSmithKline's back. This time, U.K. traders were talking up a different potential takeover--not by Pfizer, but by Johnson & Johnson or Roche.
GlaxoSmithKline is working to get its now-underperforming respiratory newcomers up to speed, to fill in as blockbuster Advair declines. But it's hoping that the first in a new class of asthma meds will help pump up its top line, too--and on that front, it got one step closer late last week.
San Diego-based Avalon Ventures has doubled up on its pipeline of programs being developed in partnership with GlaxoSmithKline. The venture group has launched three new companies, plucking new drug projects that range from cardiovascular disease, to cancer to a rare lysosomal storage disorder.
Earlier this year, Novartis became the owner of a number of new oncology assets thanks to its multibillion-dollar asset swap with GlaxoSmithKline. And Friday, it released some positive new survival data for leukemia drug Arzerra that adds to the evidence that the trade was a good one for the Swiss drugmaker.
A group of FDA advisers backed GlaxoSmithKline's latest asthma treatment for use in adults but balked at recommending it for adolescents, setting the stage for a likely approval in the fall.
Earlier this week, Chinese authorities released Peter Humphrey--a private eye linked to GlaxoSmithKline's 2013 bribery scandal--from local prison after a court reduced his sentence by about 7 months. And now, The Wall Street Journal reports that they've released his wife and partner Yu Yingzeng, too, cutting short her sentence by one month.
The recommended schedule for HPV vaccination is two or three doses, but some patients never make it back for all of the shots. This may cease to be a concern if future trials prove what scientists reported on Wednesday: A single dose of GlaxoSmithKline's Cervarix could work as well as the recommended two- or three-dose regimens at preventing the majority of cervical cancers.